Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | ADC payloads to Fc mutations: advancing bioanalysis for novel modalities 14 days 17 hours 16 mins 22 secs REGISTER NOW!

Key qualities to ensure success when outsourcing immunogenicity assay development

23 Oct 2019
Biomarkers Clinical Diagnostics Immunogenicity

immunogenicity-infographic-viracor

< Back to – In the Zone: Immunogenicity

 

 

 

Top content

  • Small molecule method development strategies with Chad Christianson
  • New AI tool predicts multiple sclerosis drug response
  • Waters upgrade Xevo MRT performance: who doesn’t want sharper, faster imaging?

Related tags

assay CRO outsourcing Viracor Eurofins
Previous article Next article

Related articles

24 MAY 2011 CHROMATOGRAPHY
Bioanalysis in Latin America: where are we and where are we going?
17 JUN 2020 NEWS
Thermo Fisher’s oncomine precision assay granted breakthrough device designation
23 AUG 2017 GENERAL INTEREST
Future trends in outsourcing: survey revisited
4 MAY 2020 JOURNAL ARTICLES
CRO commentary on the importance of harmonization and the impact of the ICH M10
15 MAR 2013 DRUG DEVELOPMENT
Antibody–drug conjugate drug development: where are the challenges?
12 JUL 2017 JOURNAL ARTICLES
Capillary microsampling in nonclinical safety assessment: practical sampling and bioanalysis from a CRO perspective
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone